Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Patients with burkitt's lymphoma have a better survival probability if treated in an academic cancer program

View Full Paper
Ask AI
Bookmark
Share

Authors

YAYsaith Orellana AscencioEAEleftheria AtallaSKSupreet Kaur

Discussion

Loading...

Member takes

Overview

Retrospective analysis shows better overall survival in burkitt lymphoma patients at academic cancer programs, suggesting benefits of systemic therapy and treatment protocols.

Key Points

  • To compare survival outcomes for patients with burkitt lymphoma treated at academic versus community cancer programs.
  • Retrospective analysis of burkitt lymphoma patients from the National Cancer Database
  • Comparative study of treatment and survival outcomes between academic and community cancer programs
  • Utilization of Kaplan-Meier and Cox regression models for overall survival analysis
  • Higher overall survival rates observed in academic cancer programs compared to community programs
  • Patients treated at academic programs had shorter time to treatment initiation
  • Higher rates of systemic therapy administered in academic cancer programs

Cite This Study

Ascencio et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d55ehttps://doi.org/10.1182/blood-2025-6311
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of facility type on outcomes for elderly patients (≥ 75 years) with Burkitt lymphoma: Real-world data of academic vs community cancer programs.2026
  2. 2The academic center effect: Better outcomes for patients with DLBCL2025
  3. 3A national lens on follicular lymphoma: Academic care linked to improved survival in 158,000 patients2025
  4. 4Academic cancer programs deliver improved long-term survival in nodular lymphocyte predominant Hodgkin lymphoma: Insights from 7,000+ United States patients2025
  5. 5Unequal outcomes: The role of institutional setting in the management of primary CNS lymphoma2025 · 1 citations